• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人补体第六和第七成分的纯化且不丧失溶血活性。

Purification of the sixth and seventh component of human complement without loss of hemolytic activity.

作者信息

Podack E R, Kolb W P, Müller-Eberhard H J

出版信息

J Immunol. 1976 Feb;116(2):263-9.

PMID:1249415
Abstract

Procedures for the isolation of the human complement proteins C6 and C7 have been described. These procedures allow isolation of the two proteins without any loss of hemolytic activity. Apparent activity gains of 160% and 140% were observed for C6 and C7, respectively, when the activity of the isolated proteins was compared with their activity in serum. The recovery of C6 was 3.5 to 11% and that of C7 was 7 to 13% of the amount present in serum. C6 has a m.w.of 128,000 and an electrophoretic mobility at pH 8.6 of -2.6 times 10(-5) cm2 s-1 v-1. C7 has a m.w. of 121,000 and an identical electrophoretic mobility. With 3 times 10(7) assay cells, 63% hemolysis was achieved with 1 ng of C6 and 3.8 ng C7. On polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate and after reduction with mercaptoethanol, C6 and C7 behaved as single polypeptide chain proteins.

摘要

已描述了分离人补体蛋白C6和C7的方法。这些方法能够分离出这两种蛋白,且溶血活性无任何损失。当将分离出的蛋白活性与其在血清中的活性进行比较时,分别观察到C6和C7的表观活性增加了160%和140%。C6的回收率为血清中含量的3.5%至11%,C7的回收率为血清中含量的7%至13%。C6的分子量为128,000,在pH 8.6时的电泳迁移率为-2.6×10(-5) cm2 s-1 v-1。C7的分子量为121,000,电泳迁移率相同。使用3×10(7)个测定细胞,1 ng C6和3.8 ng C7可实现63%的溶血。在十二烷基硫酸钠存在下并经巯基乙醇还原后进行聚丙烯酰胺凝胶电泳时,C6和C7表现为单条多肽链蛋白。

相似文献

1
Purification of the sixth and seventh component of human complement without loss of hemolytic activity.人补体第六和第七成分的纯化且不丧失溶血活性。
J Immunol. 1976 Feb;116(2):263-9.
2
Structural similarities between C6 and C7 of human complement.
J Immunol. 1979 Sep;123(3):1071-7.
3
Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
J Immunol. 1995 May 1;154(9):4734-40.
4
The SC5b-7 complex: formation, isolation, properties, and subunit composition.SC5b - 7复合物:形成、分离、性质及亚基组成
J Immunol. 1977 Dec;119(6):2024-9.
5
The complex of C5b and C6: isolation, characterization, and identification of a modified form of C5b consisting of three polypeptide chains.C5b与C6的复合物:一种由三条多肽链组成的C5b修饰形式的分离、特性鉴定及识别
J Immunol. 1978 Jun;120(6):2008-15.
6
Inherited deficiency of the seventh component of complement associated with nephritis. Propensity to formation of C56 and related C7-consuming activity.与肾炎相关的遗传性补体第七成分缺乏。形成C56及相关C7消耗活性的倾向。
J Clin Invest. 1978 Jun;61(6):1602-10. doi: 10.1172/JCI109080.
7
Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.人补体系统第五和第六成分的激活:酸性条件下C6依赖性的C5裂解及双分子溶解复合物C5b,6a的形成
J Immunol. 1983 Aug;131(2):892-8.
8
The isolation and functional purification of the first seven components of canine hemolytic complement.犬溶血补体前七种成分的分离与功能纯化。
Immunochemistry. 1976 Oct;13(10):823-9. doi: 10.1016/0019-2791(76)90183-x.
9
Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.偏差溶解:补体溶解活性向未致敏细胞的转移。IV. 活性的部分分离。
Z Immunitatsforsch Immunobiol. 1977 Apr;153(1):48-59.
10
A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.一例人类补体第七成分缺乏症。C7 缺乏血清的生物学特性及一种 C7 灭活因子的描述。
Clin Exp Immunol. 1975 Feb;19(2):223-35.

引用本文的文献

1
Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung.补体可溶性复合物可增加大鼠肺单根微血管的水导率。
J Clin Invest. 1993 Jan;91(1):103-9. doi: 10.1172/JCI116157.
2
Human complement in the arachidonic acid transformation pathway in platelets.血小板中花生四烯酸转化途径中的人类补体。
J Exp Med. 1981 Feb 1;153(2):257-68. doi: 10.1084/jem.153.2.257.
3
Molecular weight of the membrane C5b-9 complex of human complement: characterization of the terminal complex as a C5b-9 monomer.人补体膜攻击复合物C5b-9的分子量:末端复合物作为C5b-9单体的特性
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1818-22. doi: 10.1073/pnas.78.3.1818.
4
The genetics of the sixth and seventh components of complement in the dog: polymorphism, linkage, locus duplication, and silent alleles.犬补体第六和第七成分的遗传学:多态性、连锁、基因座重复及沉默等位基因
Biochem Genet. 1983 Feb;21(1-2):81-91. doi: 10.1007/BF02395393.
5
Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family.荷兰一个家族中补体第六成分和凝血因子 VIII 凝血活性的联合遗传性缺乏。
Clin Exp Immunol. 1982 Jun;48(3):733-8.
6
Human platelet activation by C3a and C3a des-arg.C3a和C3a去精氨酸对人血小板的激活作用
J Exp Med. 1983 Aug 1;158(2):603-15. doi: 10.1084/jem.158.2.603.
7
Genetic polymorphism of the sixth component of complement (C6) in mice.小鼠补体第六成分(C6)的基因多态性
Immunogenetics. 1984;20(6):633-8. doi: 10.1007/BF00430321.
8
Genetic polymorphism of complement C6 and haplotype analysis between C6 and C7 in a Japanese population.
Hum Genet. 1984;68(2):138-41. doi: 10.1007/BF00279303.
9
Genetic polymorphism and linkage of the sixth and seventh complement components (C6 and C7) in the common marmoset.普通狨猴第六和第七补体成分(C6和C7)的遗传多态性及连锁分析
Biochem Genet. 1984 Feb;22(1-2):51-63. doi: 10.1007/BF00499286.
10
The membrane attack complex.膜攻击复合物
Springer Semin Immunopathol. 1984;7(2-3):93-141. doi: 10.1007/BF01893017.